EPAS1 and neoplasm: Interestingly, SLC7A5 silencing in 786-O cells to levels similar to those obtained after HIF-2α suppression attenuated mTORC1 activity and reduced xenograft size, consistent with the critical tumor-promoting properties of HIF-2α [176].